Teva Pharmaceutical Industries

NYSE:TEVA Stock Report

Mkt Cap: US$9.9b

Teva Pharmaceutical Industries Future Growth

How is Teva Pharmaceutical Industries forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


57.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TEVA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: TEVA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: TEVA is expected to become profitable in the next 3 years.

Revenue vs Market: TEVA's revenue (1.6% per year) is forecast to grow slower than the US market (6.9% per year).

High Growth Revenue: TEVA's revenue (1.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TEVA's Return on Equity is forecast to be high in 3 years time (23.4%)


Discover growth companies